- Home
- SUNE vs CHRO Comparison
SUNE vs CHRO Comparison
Compare SUNE & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNE
- CHRO
- Stock Information
- Founded
- SUNE 1969
- CHRO 2002
- Country
- SUNE United States
- CHRO United States
- Employees
- SUNE N/A
- CHRO N/A
- Industry
- SUNE
- CHRO
- Sector
- SUNE
- CHRO
- Exchange
- SUNE NYSE
- CHRO Nasdaq
- Market Cap
- SUNE 4.5M
- CHRO 4.2M
- IPO Year
- SUNE N/A
- CHRO 2024
- Fundamental
- Price
- SUNE $2.56
- CHRO $0.64
- Analyst Decision
- SUNE
- CHRO Strong Buy
- Analyst Count
- SUNE 0
- CHRO 1
- Target Price
- SUNE N/A
- CHRO N/A
- AVG Volume (30 Days)
- SUNE 60.3K
- CHRO 161.0K
- Earning Date
- SUNE 01-01-0001
- CHRO 11-13-2024
- Dividend Yield
- SUNE N/A
- CHRO N/A
- EPS Growth
- SUNE N/A
- CHRO N/A
- EPS
- SUNE N/A
- CHRO N/A
- Revenue
- SUNE $60,929,299.00
- CHRO N/A
- Revenue This Year
- SUNE N/A
- CHRO N/A
- Revenue Next Year
- SUNE N/A
- CHRO N/A
- P/E Ratio
- SUNE N/A
- CHRO N/A
- Revenue Growth
- SUNE N/A
- CHRO N/A
- 52 Week Low
- SUNE $2.50
- CHRO $0.45
- 52 Week High
- SUNE $495.00
- CHRO $6.00
- Technical
- Relative Strength Index (RSI)
- SUNE N/A
- CHRO 49.55
- Support Level
- SUNE N/A
- CHRO $0.56
- Resistance Level
- SUNE N/A
- CHRO $0.69
- Average True Range (ATR)
- SUNE 0.00
- CHRO 0.09
- MACD
- SUNE 0.00
- CHRO -0.00
- Stochastic Oscillator
- SUNE 0.00
- CHRO 24.53
About SUNE SUNATION ENERGY INC
SUNation Energy Inc formerly Pineapple Energy Inc provides households with sustainable solar energy, back-up power and security, control and predictability, and cost savings. The company provides a full range of installation services, including the design, engineering, procurement, permitting, construction, grid connection, warranty, monitoring and maintenance of residential solar energy systems. It also offers battery storage to customers in select markets and serves a limited number of enterprise customers.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.